Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2025-12-29 @ 2:10 AM
Study NCT ID:
NCT02476968
Status:
COMPLETED
Last Update Posted:
2022-09-10
First Post:
2015-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-10
First Submit QC Date:
None
Study First Post Date:
2015-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-29
Results First Submit QC Date:
None
Results First Post Date:
2021-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-17
Last Update Post Date:
2022-09-10
Last Update Post Date Type:
ACTUAL